Exact Mass: 363.1331

Exact Mass Matches: 363.1331

Found 109 metabolites which its exact mass value is equals to given mass value 363.1331, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Methixene hydrochloride

Metixene hydrochloride hydrate

C20H26ClNOS (363.1424)


C78272 - Agent Affecting Nervous System > C66880 - Anticholinergic Agent

   

(4-(2-((2-(3-Chlorophenyl)-2-hydroxyethyl)amino)propyl)phenoxy)acetic acid

2-(4-((2R)-2-(((2R)-2-(3-Chlorophenyl)-2-hydroxyethyl)amino)propyl)phenoxy)acetic acid

C19H22ClNO4 (363.1237)


D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D000322 - Adrenergic Agonists

   

4-[[5-Chloro-4-(2,4,6-trimethylanilino)pyrimidin-2-yl]amino]benzonitrile

4-({5-chloro-4-[(2,4,6-trimethylphenyl)amino]pyrimidin-2-yl}amino)benzonitrile

C20H18ClN5 (363.1251)


   

N-Biotinyl-4-aminobenzoic acid

4-(5-{2-oxo-hexahydro-1H-thieno[3,4-d]imidazol-4-yl}pentanamido)benzoic acid

C17H21N3O4S (363.1253)


   

Biotinyl-p-aminobenzoate

5-{2-hydroxy-1H,3ah,4H,6H,6ah-thieno[3,4-D]imidazol-6-yl}pentanoyl 4-aminobenzoic acid

C17H21N3O4S (363.1253)


   

2-[[[4-(3-Benzylcyclobutyl)-1,3-thiazol-2-yl]diazenyl]methyl]phenol

2-({2-[4-(3-benzylcyclobutyl)-1,3-thiazol-2-yl]diazen-1-yl}methyl)phenol

C21H21N3OS (363.1405)


   

corytuberine

corytuberine

C19H21NO4.HCl (363.1237)


   

(+)-16-Hydroxy-9-O-demethylgalwesine

(+)-16-Hydroxy-9-O-demethylgalwesine

C18H21NO7 (363.1318)


   

Maremycin B

Maremycin B

C17H21N3O4S (363.1253)


   

Kahakamide B

Kahakamide B

C17H21N3O6 (363.143)


   

AOB5991

AOB5991

C19H22ClNO4 (363.1237)


   

MMV688178

MMV688178

C24H17N3O (363.1372)


   

2,2-Bis(3-indolyl)indoxyl

2,2-Bis(3-indolyl)indoxyl

C24H17N3O (363.1372)


   

N-Methyl Mitomycin A

N-Methyl Mitomycin A

C17H21N3O6 (363.143)


   

hostasine

hostasine

C18H21NO7 (363.1318)


   

3,3-Bis(1H-indole-3-yl)-2-indolinone

3,3-Bis(1H-indole-3-yl)-2-indolinone

C24H17N3O (363.1372)


   

glioperazine B

glioperazine B

C17H21N3O4S (363.1253)


A member of the class of 2,5-diketopiperazines with an indole substituent. It is a microbial metabolite isolated from the mycelia of a liquid fermentation culture of the fungus, Bionectria byssicola and has been shown to exhibit antibacterial activity against Staphylococcus aureus.

   

Transvalencin Z

Transvalencin Z

C17H21N3O6 (363.143)


   

(R)-2-(6-O-trans-2-butenoyl-beta-D-glucopyranosyloxy)-phenylacetonitrile

(R)-2-(6-O-trans-2-butenoyl-beta-D-glucopyranosyloxy)-phenylacetonitrile

C18H21NO7 (363.1318)


   

Glu Ser Glu

Glu Ser Glu

C13H21N3O9 (363.1278)


   

Asp Thr Glu

Asp Thr Glu

C13H21N3O9 (363.1278)


   

Thr Glu Asp

Thr Glu Asp

C13H21N3O9 (363.1278)


   

Glu Asp Thr

Glu Asp Thr

C13H21N3O9 (363.1278)


   

Ser Glu Glu

Ser Glu Glu

C13H21N3O9 (363.1278)


   

Glu Glu Ser

Glu Glu Ser

C13H21N3O9 (363.1278)


   

Glu Thr Asp

Glu Thr Asp

C13H21N3O9 (363.1278)


   

Asp Glu Thr

Asp Glu Thr

C13H21N3O9 (363.1278)


   

GSK 264220A

GSK 264220A

C17H21N3O4S (363.1253)


   

Thr Asp Glu

Thr Asp Glu

C13H21N3O9 (363.1278)


   

Naloxone HCl

Naloxone hydrochloride

C19H22ClNO4 (363.1237)


D002492 - Central Nervous System Depressants > D009294 - Narcotics > D053610 - Opiate Alkaloids D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D009292 - Narcotic Antagonists C78272 - Agent Affecting Nervous System > C681 - Opiate Antagonist Naloxone hydrochloride is an antagonist of Opioid receptor. Naloxone hydrochloride alleviates opioid-overdose-induced respiratory depression. Naloxone hydrochloride may cause pulmonary edema and cardiac arrhythmias[1].

   

Naloxone hydrochloride

Naloxone hydrochloride

C19H22ClNO4 (363.1237)


   

Gly Asn Ser Ser

(2S)-2-[(2S)-2-[(2S)-2-(2-aminoacetamido)-3-carbamoylpropanamido]-3-hydroxypropanamido]-3-hydroxypropanoic acid

C12H21N5O8 (363.139)


   

Gly Ser Asn Ser

(2S)-2-[(2S)-2-[(2S)-2-(2-aminoacetamido)-3-hydroxypropanamido]-3-carbamoylpropanamido]-3-hydroxypropanoic acid

C12H21N5O8 (363.139)


   

Gly Ser Ser Asn

(2S)-2-[(2S)-2-[(2S)-2-(2-aminoacetamido)-3-hydroxypropanamido]-3-hydroxypropanamido]-3-carbamoylpropanoic acid

C12H21N5O8 (363.139)


   

Asn Gly Ser Ser

(2S)-2-[(2S)-2-{2-[(2S)-2-amino-3-carbamoylpropanamido]acetamido}-3-hydroxypropanamido]-3-hydroxypropanoic acid

C12H21N5O8 (363.139)


   

Asn Ser Gly Ser

(2S)-2-{2-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]-3-hydroxypropanamido]acetamido}-3-hydroxypropanoic acid

C12H21N5O8 (363.139)


   

Asn Ser Ser Gly

2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]-3-hydroxypropanamido]-3-hydroxypropanamido]acetic acid

C12H21N5O8 (363.139)


   

Ser Gly Asn Ser

(2S)-2-[(2S)-2-{2-[(2S)-2-amino-3-hydroxypropanamido]acetamido}-3-carbamoylpropanamido]-3-hydroxypropanoic acid

C12H21N5O8 (363.139)


   

Ser Gly Ser Asn

(2S)-2-[(2S)-2-{2-[(2S)-2-amino-3-hydroxypropanamido]acetamido}-3-hydroxypropanamido]-3-carbamoylpropanoic acid

C12H21N5O8 (363.139)


   

Ser Asn Gly Ser

(2S)-2-{2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-carbamoylpropanamido]acetamido}-3-hydroxypropanoic acid

C12H21N5O8 (363.139)


   

Ser Asn Ser Gly

2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-carbamoylpropanamido]-3-hydroxypropanamido]acetic acid

C12H21N5O8 (363.139)


   

Ser Ser Gly Asn

(2S)-2-{2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-hydroxypropanamido]acetamido}-3-carbamoylpropanoic acid

C12H21N5O8 (363.139)


   

Ser Ser Asn Gly

2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-hydroxypropanamido]-3-carbamoylpropanamido]acetic acid

C12H21N5O8 (363.139)


   

GSK264220A

N-[2-methyl-5-(1-piperidinylsulfonyl)-3-furanyl]-N-phenyl-urea

C17H21N3O4S (363.1253)


   

Serabelisib

Serabelisib

C19H17N5O3 (363.1331)


C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C2152 - Phosphatidylinositide 3-Kinase Inhibitor C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor C274 - Antineoplastic Agent > C1742 - Angiogenesis Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor D004791 - Enzyme Inhibitors

   

B-Paba

4-[5-(2-oxohexahydrothieno[3,4-d]imidazol-6-yl)pentanoylamino]benzoic acid

C17H21N3O4S (363.1253)


   

S-Tritylcysteine

S-Trityl-L-cysteine

C22H21NO2S (363.1293)


   

4-(4-BENZYLPIPERAZINO)-1H-INDOLE DIHYDROCHLORIDE MONOHYDRATE

4-(4-BENZYLPIPERAZINO)-1H-INDOLE DIHYDROCHLORIDE MONOHYDRATE

C19H23Cl2N3 (363.1269)


   

[4-(Carbazol-9-yl)-1,1-biphenyl-4-yl]boronic acid

[4-(Carbazol-9-yl)-1,1-biphenyl-4-yl]boronic acid

C24H18BNO2 (363.1431)


   

(6,9-Diphenyl-9H-carbazol-3-yl)boronic acid

(6,9-Diphenyl-9H-carbazol-3-yl)boronic acid

C24H18BNO2 (363.1431)


   

Dibenzyl L-glutamate hydrochloride

Dibenzyl L-glutamate hydrochloride

C19H22ClNO4 (363.1237)


   

n-methoxy-n-methyl(triphenyl-phosphoranylidene)acetamide

n-methoxy-n-methyl(triphenyl-phosphoranylidene)acetamide

C22H22NO2P (363.1388)


   

S-Trityl-D-cysteine

S-Trityl-D-cysteine

C22H21NO2S (363.1293)


   

h-d-glu(obzl)-obzl hcl

h-d-glu(obzl)-obzl hcl

C19H22ClNO4 (363.1237)


   

BOLDINE HYDROCHLORIDE

BOLDINE HYDROCHLORIDE

C19H22ClNO4 (363.1237)


   

1,2,3,4-Tetrahydro-6,7-dimethoxy-3-isoquinolinecarboxylic acid phenylmethyl ester hydrochloride

1,2,3,4-Tetrahydro-6,7-dimethoxy-3-isoquinolinecarboxylic acid phenylmethyl ester hydrochloride

C19H22ClNO4 (363.1237)


   

(4-(N-ISOPROPYL-N-(4-METHOXYBENZYL)SULFAMOYL)PHENYL)BORONIC ACID

(4-(N-ISOPROPYL-N-(4-METHOXYBENZYL)SULFAMOYL)PHENYL)BORONIC ACID

C17H22BNO5S (363.1312)


   

Thiphenamil hydrochloride

S-[2-(diethylamino)ethyl] alpha-phenylbenzeneethanethioate hydrochloride

C20H26ClNOS (363.1424)


C78272 - Agent Affecting Nervous System > C66880 - Anticholinergic Agent > C29704 - Antimuscarinic Agent

   

antazoline

Antazoline phosphate

C17H22N3O4P (363.1348)


D018377 - Neurotransmitter Agents > D018494 - Histamine Agents > D006633 - Histamine Antagonists C308 - Immunotherapeutic Agent > C29578 - Histamine-1 Receptor Antagonist D018926 - Anti-Allergic Agents

   

Tritylcysteine

S-Tritylcysteine

C22H21NO2S (363.1293)


   

9-(4-Biphenylyl)-3-boronic acid

9-(4-Biphenylyl)-3-boronic acid

C24H18BNO2 (363.1431)


   

9-(Biphenyl-4-yl)carbazole-2-boronic acid

9-(Biphenyl-4-yl)carbazole-2-boronic acid

C24H18BNO2 (363.1431)


   

GLY-PRO 4-METHOXY-BETA-NAPHTHYLAMIDE HYDROCHLORIDE

GLY-PRO 4-METHOXY-BETA-NAPHTHYLAMIDE HYDROCHLORIDE

C18H22ClN3O3 (363.135)


   

4-[(5,6-DIHYDRO[2,3-BIPYRIDIN]-3(4H)-YLIDENE)METHYL]-N,N-DIMETHYLBENZENAMINE DIHYDROCHLORIDE

4-[(5,6-DIHYDRO[2,3-BIPYRIDIN]-3(4H)-YLIDENE)METHYL]-N,N-DIMETHYLBENZENAMINE DIHYDROCHLORIDE

C19H23Cl2N3 (363.1269)


   

(3-(N-Isopropyl-N-(4-methoxybenzyl)sulfamoyl)phenyl)boronic acid

(3-(N-Isopropyl-N-(4-methoxybenzyl)sulfamoyl)phenyl)boronic acid

C17H22BNO5S (363.1312)


   

8-DeMethoxy-8-fluoro Gatifloxacin

8-DeMethoxy-8-fluoro Gatifloxacin

C18H19F2N3O3 (363.1394)


   

2-(4-((2R)-2-(((2R)-2-(3-Chlorophenyl)-2-hydroxyethyl)amino)propyl)phenoxy)acetic acid

2-(4-((2R)-2-(((2R)-2-(3-Chlorophenyl)-2-hydroxyethyl)amino)propyl)phenoxy)acetic acid

C19H22ClNO4 (363.1237)


D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D000322 - Adrenergic Agonists

   

3-(1-azepanylsulfonyl)-N-(3-isoxazolyl)-4-methylbenzamide

3-(1-azepanylsulfonyl)-N-(3-isoxazolyl)-4-methylbenzamide

C17H21N3O4S (363.1253)


   

{4-[(2R)-pyrrolidin-2-ylmethoxy]phenyl}(4-thiophen-3-ylphenyl)methanone

{4-[(2R)-pyrrolidin-2-ylmethoxy]phenyl}(4-thiophen-3-ylphenyl)methanone

C22H21NO2S (363.1293)


   

5-[6-(4-phenoxyphenyl)pyrazin-2-yl]-1H-indole

5-[6-(4-phenoxyphenyl)pyrazin-2-yl]-1H-indole

C24H17N3O (363.1372)


   

3-[[(E)-4-Methoxy-4-oxo-2-butenoyl]amino]-L-Ala-L-Phe-OH

3-[[(E)-4-Methoxy-4-oxo-2-butenoyl]amino]-L-Ala-L-Phe-OH

C17H21N3O6 (363.143)


   

N-acetyl-alpha-D-muramoyl-L-alaninate

N-acetyl-alpha-D-muramoyl-L-alaninate

C14H23N2O9- (363.1403)


The carbohydrate acid derivative anion formed by loss of a proton from the carboxy group of N-acetyl-alpha-D-muramoyl-L-alanine; principal microspecies at pH 7.3.

   

3-{[(2E)-4-methoxy-4-oxobut-2-enoyl]amino}alanyl-L-phenylalanine

3-{[(2E)-4-methoxy-4-oxobut-2-enoyl]amino}alanyl-L-phenylalanine

C17H21N3O6 (363.143)


   

5-(2-Oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl)pentanoyl 4-aminobenzoate

5-(2-Oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl)pentanoyl 4-aminobenzoate

C17H21N3O4S (363.1253)


   

Maremycin A

Maremycin A

C17H21N3O4S (363.1253)


   

phe-FMDP

phe-FMDP

C17H21N3O6 (363.143)


A dipeptide composed of 3-{[(2E)-4-methoxy-4-oxobut-2-enoyl]amino}alanine and L-phenylalanine joined by peptide linkages.

   

2-[(1-Amino-1-oxopropan-2-yl)thio]-3-butyl-4-oxo-7-quinazolinecarboxylic acid methyl ester

2-[(1-Amino-1-oxopropan-2-yl)thio]-3-butyl-4-oxo-7-quinazolinecarboxylic acid methyl ester

C17H21N3O4S (363.1253)


   

1-(4,6-dimethoxy-1,3,5-triazin-2-yl)-N-(thiophen-2-ylmethyl)-4-piperidinecarboxamide

1-(4,6-dimethoxy-1,3,5-triazin-2-yl)-N-(thiophen-2-ylmethyl)-4-piperidinecarboxamide

C16H21N5O3S (363.1365)


   

3-[[4-[(4-chlorophenyl)methyl]-4-(hydroxymethyl)-1-piperidinyl]-oxomethyl]-4,5-dihydro-1H-pyridazin-6-one

3-[[4-[(4-chlorophenyl)methyl]-4-(hydroxymethyl)-1-piperidinyl]-oxomethyl]-4,5-dihydro-1H-pyridazin-6-one

C18H22ClN3O3 (363.135)


   

N-[(E)-(5-Morpholin-4-ylthiophen-2-yl)methylideneamino]-N-phenylaniline

N-[(E)-(5-Morpholin-4-ylthiophen-2-yl)methylideneamino]-N-phenylaniline

C21H21N3OS (363.1405)


   

N-[[(2S)-3beta-(Ethoxycarbonyl)aziridine-2alpha-yl]carbonyl]-Gly-Gly-OBzl

N-[[(2S)-3beta-(Ethoxycarbonyl)aziridine-2alpha-yl]carbonyl]-Gly-Gly-OBzl

C17H21N3O6 (363.143)


   

Ser-Glu-Glu

Ser-Glu-Glu

C13H21N3O9 (363.1278)


   

Thr-Glu-Asp

Thr-Glu-Asp

C13H21N3O9 (363.1278)


   

Thr-Asp-Glu

Thr-Asp-Glu

C13H21N3O9 (363.1278)


   

Asp-Glu-Thr

Asp-Glu-Thr

C13H21N3O9 (363.1278)


   

Glu-Glu-Ser

Glu-Glu-Ser

C13H21N3O9 (363.1278)


   

Glu-Ser-Glu

Glu-Ser-Glu

C13H21N3O9 (363.1278)


   

N-acetyl-D-muramoyl-L-alaninate

N-acetyl-D-muramoyl-L-alaninate

C14H23N2O9- (363.1403)


   

hydron;1-methyl-3-(9H-thioxanthen-9-ylmethyl)piperidine;chloride;hydrate

hydron;1-methyl-3-(9H-thioxanthen-9-ylmethyl)piperidine;chloride;hydrate

C20H26ClNOS (363.1424)


   

Glu-Asp-Thr

Glu-Asp-Thr

C13H21N3O9 (363.1278)


   

Glu-Thr-Asp

Glu-Thr-Asp

C13H21N3O9 (363.1278)


   

Asp-Thr-Glu

Asp-Thr-Glu

C13H21N3O9 (363.1278)


   

SCD1 inhibitor-4

SCD1 inhibitor-4

C17H16F3N5O (363.1307)


SCD1 inhibitor-4 is a potent, orally active stearoylCoA desaturase-1 (SCD1) inhibitor. SCD1 inhibitor-4 can be used for the research of diabetes[1].

   

2-amino-3-[(triphenylmethyl)sulfanyl]propanoic acid

2-amino-3-[(triphenylmethyl)sulfanyl]propanoic acid

C22H21NO2S (363.1293)


   

(2s,4s,5s,6s)-4,5-dihydroxy-6-[3-(c-hydroxycarbonimidoylmethyl)-4-methoxyindol-1-yl]oxane-2-carboximidic acid

(2s,4s,5s,6s)-4,5-dihydroxy-6-[3-(c-hydroxycarbonimidoylmethyl)-4-methoxyindol-1-yl]oxane-2-carboximidic acid

C17H21N3O6 (363.143)


   

(2s)-2-({hydroxy[(4s)-2-(2-hydroxyphenyl)-4,5-dihydro-1,3-oxazol-4-yl]methylidene}amino)-6-[(hydroxymethylidene)amino]hexanoic acid

(2s)-2-({hydroxy[(4s)-2-(2-hydroxyphenyl)-4,5-dihydro-1,3-oxazol-4-yl]methylidene}amino)-6-[(hydroxymethylidene)amino]hexanoic acid

C17H21N3O6 (363.143)


   

(2s,3s,4'r)-4'-(acetyloxy)-1'-methoxy-5'-methylidene-2'-oxo-3-[(1e)-prop-1-en-1-yl]-7-oxaspiro[bicyclo[2.2.1]heptane-2,3'-pyrrolidin]-5-en-6-yl acetate

(2s,3s,4'r)-4'-(acetyloxy)-1'-methoxy-5'-methylidene-2'-oxo-3-[(1e)-prop-1-en-1-yl]-7-oxaspiro[bicyclo[2.2.1]heptane-2,3'-pyrrolidin]-5-en-6-yl acetate

C18H21NO7 (363.1318)


   

(1r,5's,6'r,7'ar)-5',6,6'-trihydroxy-4,5-dimethoxy-1'-methyl-3',5',6',7'a-tetrahydro-2'h-spiro[2-benzofuran-1,7'-indol]-3-one

(1r,5's,6'r,7'ar)-5',6,6'-trihydroxy-4,5-dimethoxy-1'-methyl-3',5',6',7'a-tetrahydro-2'h-spiro[2-benzofuran-1,7'-indol]-3-one

C18H21NO7 (363.1318)


   

{6-[cyano(phenyl)methoxy]-3,4,5-trihydroxyoxan-2-yl}methyl but-2-enoate

{6-[cyano(phenyl)methoxy]-3,4,5-trihydroxyoxan-2-yl}methyl but-2-enoate

C18H21NO7 (363.1318)


   

(3r)-3-[(1r)-1-[(2s,5r)-3,6-dihydroxy-5-[(methylsulfanyl)methyl]-2,5-dihydropyrazin-2-yl]ethyl]-3-hydroxy-1-methylindol-2-one

(3r)-3-[(1r)-1-[(2s,5r)-3,6-dihydroxy-5-[(methylsulfanyl)methyl]-2,5-dihydropyrazin-2-yl]ethyl]-3-hydroxy-1-methylindol-2-one

C17H21N3O4S (363.1253)


   

(1r,2s,6r,8s,9s,10r)-1,15-dihydroxy-9,16-dimethoxy-3-methyl-7,11-dioxa-3-azapentacyclo[8.8.0.0²,⁶.0⁶,⁸.0¹³,¹⁸]octadeca-13(18),14,16-trien-12-one

(1r,2s,6r,8s,9s,10r)-1,15-dihydroxy-9,16-dimethoxy-3-methyl-7,11-dioxa-3-azapentacyclo[8.8.0.0²,⁶.0⁶,⁸.0¹³,¹⁸]octadeca-13(18),14,16-trien-12-one

C18H21NO7 (363.1318)


   

2-({hydroxy[2-(2-hydroxyphenyl)-4,5-dihydro-1,3-oxazol-4-yl]methylidene}amino)-6-[(hydroxymethylidene)amino]hexanoic acid

2-({hydroxy[2-(2-hydroxyphenyl)-4,5-dihydro-1,3-oxazol-4-yl]methylidene}amino)-6-[(hydroxymethylidene)amino]hexanoic acid

C17H21N3O6 (363.143)


   

4'-(acetyloxy)-1'-methoxy-5'-methylidene-2'-oxo-3-(prop-1-en-1-yl)-7-oxaspiro[bicyclo[2.2.1]heptane-2,3'-pyrrolidin]-5-en-6-yl acetate

4'-(acetyloxy)-1'-methoxy-5'-methylidene-2'-oxo-3-(prop-1-en-1-yl)-7-oxaspiro[bicyclo[2.2.1]heptane-2,3'-pyrrolidin]-5-en-6-yl acetate

C18H21NO7 (363.1318)


   

3-(1h-indol-3-yl)-1'h-[3,3'-biindol]-2-ol

3-(1h-indol-3-yl)-1'h-[3,3'-biindol]-2-ol

C24H17N3O (363.1372)


   

(3s,6s)-3-(1-hydroxyethyl)-6-(1h-indol-3-ylmethyl)-6-methoxy-3-(methylsulfanyl)pyrazine-2,5-diol

(3s,6s)-3-(1-hydroxyethyl)-6-(1h-indol-3-ylmethyl)-6-methoxy-3-(methylsulfanyl)pyrazine-2,5-diol

C17H21N3O4S (363.1253)


   

1,15-dihydroxy-9,16-dimethoxy-3-methyl-7,11-dioxa-3-azapentacyclo[8.8.0.0²,⁶.0⁶,⁸.0¹³,¹⁸]octadeca-13(18),14,16-trien-12-one

1,15-dihydroxy-9,16-dimethoxy-3-methyl-7,11-dioxa-3-azapentacyclo[8.8.0.0²,⁶.0⁶,⁸.0¹³,¹⁸]octadeca-13(18),14,16-trien-12-one

C18H21NO7 (363.1318)


   

[(2r,3s,4s,5r,6r)-6-[(r)-cyano(phenyl)methoxy]-3,4,5-trihydroxyoxan-2-yl]methyl (2e)-but-2-enoate

[(2r,3s,4s,5r,6r)-6-[(r)-cyano(phenyl)methoxy]-3,4,5-trihydroxyoxan-2-yl]methyl (2e)-but-2-enoate

C18H21NO7 (363.1318)


   

(3s)-3-[(1r)-1-[(2s,5r)-3,6-dihydroxy-5-[(methylsulfanyl)methyl]-2,5-dihydropyrazin-2-yl]ethyl]-3-hydroxy-1-methylindol-2-one

(3s)-3-[(1r)-1-[(2s,5r)-3,6-dihydroxy-5-[(methylsulfanyl)methyl]-2,5-dihydropyrazin-2-yl]ethyl]-3-hydroxy-1-methylindol-2-one

C17H21N3O4S (363.1253)


   

(2s)-2-[(2-amino-1-hydroxy-3-{[(2e)-1-hydroxy-4-methoxy-4-oxobut-2-en-1-ylidene]amino}propylidene)amino]-3-phenylpropanoic acid

(2s)-2-[(2-amino-1-hydroxy-3-{[(2e)-1-hydroxy-4-methoxy-4-oxobut-2-en-1-ylidene]amino}propylidene)amino]-3-phenylpropanoic acid

C17H21N3O6 (363.143)